Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3297589 | 0.84 | CNR2 (0.46) | CNR2CNR1 | |
| SCHEMBL3298669 | 0.81 | CNR2 (0.46) | CNR2CNR1 | |
| SCHEMBL3294319 | 0.79 | CNR2 (0.37) | CNR2CNR1 | |
| SCHEMBL3294369 | 0.78 | S1PR1 (0.33) | CNR2CNR1 | |
| SCHEMBL5613165 | 0.77 | CNR2 (0.74) | CNR2CNR1 | |
| SCHEMBL990538 | 0.77 | CNR2 (0.54) | CNR2CNR1 | |
| SCHEMBL3297698 | 0.76 | CNR2 (0.44) | CNR2CNR1 | |
| SCHEMBL3303310 | 0.76 | CNR2 (0.44) | CNR2CNR1 | |
| SCHEMBL8768823 | 0.76 | CNR2 (0.67) | CNR2CNR1 | |
| SCHEMBL7166616 | 0.75 | CNR2 (0.53) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7741393-B2 | Organic silicon-based compound and method of producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-22 | — | — | US | disclosed |
| US-20070203275-A1 | Organic Silicon-Based Compound And Method Of Producing The Same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203275-A1 | Organic Silicon-Based Compound And Method Of Producing The Same | ARSA, OR10J3, HDAC10 | CNR2 4285/4885CNR1 3945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.